Granulocyte transfusions as treatment or prophylaxis for fungal infections?

Current Opinion in Investigational Drugs

Volumn 4, Issue 8, 2003, Pages 921-925

  Van Burik, Jo Anne H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; ANTIPYRETIC AGENT; CORTICOSTEROID; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; STEROID;

ARTHRALGIA; BLOOD DONOR; BLOOD TRANSFUSION; BONE PAIN; CELL COUNT; CELL TRANSFER; CHILL; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE TRANSMISSION; DRUG COST; DRUG FATALITY; DYSPNEA; FAMILY; FEVER; GRANULOCYTE FUNCTION; GRANULOCYTE TRANSFUSION; HEADACHE; HEALTH CARE COST; HUMAN; HYPOXIA; INFECTION CONTROL; INFECTION PREVENTION; INSOMNIA; LUNG DISEASE; MYCOSIS; NEUTROPENIA; PROPHYLAXIS; RESOURCE MANAGEMENT; REVIEW; RISK ASSESSMENT; SCREENING TEST; SIDE EFFECT; SPLEEN RUPTURE; SPLENOMEGALY; TREATMENT INDICATION; TREATMENT PLANNING; VIRUS INFECTION;

AGRANULOCYTOSIS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; LEUKOCYTE TRANSFUSION; MYCOSES; OPPORTUNISTIC INFECTIONS;

EID: 0141719642     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Graw RG Jr, Herzig G, Perry S, Henderson ES: Normal granulocyte transfusion therapy: Treatment of septicemia due to Gram-negative bacteria. N Engl J Med (1972) 287(8):367-371.
2. Herzig RH, Herzig GP, Graw RG Jr, Bull MI, Ray KK: Successful granulocyte transfusion therapy for Gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med (1977) 296(13):701-705.
3. Higby DJ, Yates JW, Henderson ES, Holland JF: Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med (1975) 292(15):761-766.
4. Alavi JB, Root RK, Djerassi I, Evans AE, Gluckman SJ, MacGregor RR, Guerry D, Schreiber AD, Shaw JM, Koch P, Cooper RA: A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med (1977) 296(13):706-711.
5. Vamvakas EC, Pineda AA: Meta-analysis of clinical studies of the efficacy of granulocyte transfusion in the treatment of bacterial sepsis. J Clin Apheresis (1996) 11(1):1-9. Meta-analysis was used to explain disagreements across controlled clinical studies from 1970 to 1994. Patients receiving adequate doses of granulocytes experienced significant benefit.
6. Klein HG, Strauss RG, Schiffer CA: Granulocyte transfusion therapy. Semin Hematol (1996) 33(4):359-368.
7. Fortuny IE, Bloomfield CD, Hadlock DC, Goldman A, Kennedy BJ, McCullogh JJ: Granulocyte transfusion: A controlled study in patients with acute nonlymphocytic leukemia. Transfusion (1975) 15(6):548-558.
8. Winston DJ, Ho WG, Gale RP: Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med (1982) 97(4):509-515.
9. Wiltbank TB, Nusbacher J, Higby DJ, MacPherson JL: Abdominal pain in donors during filtration leukapheresis. Transfusion (1977) 17(2):159-162.
10. Dahlke MB, Shah SL, Sherwood WC, Shafer AW, Brownstein PK: Priapism during filtration leukapheresis. Transfusion (1979) 19(4):482-486.
11. Dale DC, Liles WC, Llewellyn C, Rodger E, Price TH: Neutrophil transfusions: Kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone. Transfusion (1998) 38(8):713-721.
12. Liles WC, Rodger D, Dale DC: Combined administration of G-CSF and dexamethasone for the mobilization of granulocytes in normal donors: Optimization of dosing. Transfusion (2000) 40(6):642-644.
13. Stroncek DF, Yau YY, Oblitas J, Leitman SF: Administration of G-CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G-CSF alone. Transfusion (2001) 41(8):1037-1044.
14. Stroncek DF, Matthews CL, Follmann D, Leitman SF: Kinetics of G-CSF-induced granulocyte mobilization in healthy subjects: Effects of route of administration and addition of dexamethasone. Transfusion (2002) 42(5):597-602.
15. Liles WC, Huang JE, Llewellyn C, SenGupta D, Price TH, Dale DC: A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion (1997) 37(2):182-187.
16. Hübel K, Carter RA, Liles WC, Dale DC, Price TH, Bowden RA, Rowley SD, Chauncey TR, Bensinger WI, Boeckh M: Granulocyte transfusion therapy for infections in candidates and recipients of hematopoietic stem cell transplantation: A comparative analysis of feasibility and outcome of community donors versus related donors. Transfusion (2002) 42(11):1414-1421. This article examines G-CSF- plus dexamethasone-augmented methods of granulocyte recovery. Overall clinical outcome was comparable between the 20 unrelated and 34 related donors and the 74 patients who served as controls, suggesting that unrelated community donors should be included in future efficacy trials.
17. Clift RA, Sanders JE, Thomas ED, Williams B, Buckner CD: Granulocyte transfusions for the prevention of infection in patients receivng bone-marrow transplants. N Engl J Med (1978) 298(19):1052-1057.
18. Winston DJ, Ho WG, Young LS, Gale RP: Prophylactic granulocyte transfusions during human bone marrow transplantation. Am J Med (1980) 68(6):893-897.
19. Petersen FB, Buckner CD, Clift RA, Nelson N, Counts GW, Meyers JD, Thomas ED: Prevention of nosocomial infections in marrow transplant patients: A prospective randomized comparison of systemic antibiotics versus granulocyte transfusions. Infect Control (1986) 7(12):586-592.
20. Winston DJ, Ho WG, Gale RP: Prophylactic granulocyte transfusions during chemotherapy of acute non-lymphocytic leukemia. Ann Intern Med (1981) 94(5):616-622.
21. Strauss RG, Connett JE, Gale RP, Bloomfield CD, Herzig GP, McCollough J, Maguire LC, Winston DJ, Ho W, Stump DC, Miller WV et al.: A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med (1981) 305(11):597-603.
22. Vamvakas EC, Pineda AA: Determinants of the efficacy of prophylactic granulocyte transfusions: A meta-analysis. J Clin Apheresis (1997) 12(2):74-81.
23. Strauss RG: Clinical perspectives of granulocyte transfusions: Efficacy to date. J Clin Apheresis (1995) 10(3):114-118.
24. Bhatia S, McCullough J, Perry EH, Clay M, Ramsay NK, Neglia JP: Granulocyte transfusions: Efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation. Transfusion (1994) 34(3):226-232.
25. Di Mario A, Sica S, Salutari P, Ortu La Barbera E, Marra R, Leone G: Granulocyte colony-stimulating factor-primed leukocyte transfusions in Candida tropicalis fungemia in neutropenic patients. Haematologica (1997) 82(3):362-3.
26. Dignani MC, Anaissie EJ, Hester JP, O'Brien S, Vartivarian SE, Rex JH, Kantarjian H, Jendiroba DB, Lichtiger B, Andersson BS, Freireich EJ: Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor elicited white blood cell transfusions: A pilot study. Leukemia (1997) 11(10):1621-1630.
27. Peters C, Minkov M, Matthes-Martin S, Potschger U, Witt V, Mann G, Hocker P, Worel N, Stary J, Klingebiel T, Gadner H: Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol (1999) 106(3):689-696.
28. Price TH, Bowden RA, Boeckh M, Bux J, Nelson K, Liles WC, Dale DC: Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood (2000) 95(11):3302-3309.
29. Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, Ruggeiro M, Davis M, Koci B, Hammond W, Gillio A et al.: Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol (1994) 88(4):723-730.
30. Platzbecker U, Prange-Krex G, Bornhauser M, Koch R, Soucek S, Aikele P, Haack A, Haag C, Schuler U, Berndt A, Ruth C et al.: Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion (2001) 41(2):184-189. A primary issue surrounding the use of community donors to provide G-CSF-stimulated granulocyte products even as infrequently as once monthly is long-term toxicity to an otherwise healthy individual. Patients treated with G-CSF for congenital neutropenia represent the model population for identifying which events may occur (such as splenomegaly). This study used ultrasound to prospectively follow splenomegaly among healthy donors treated with five consecutive doses of G-CSF.
31. Falzetti F, Aversa F, Minelli O, Tabilio A: Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet (1999) 353(9152):555.
32. Pitini V, Ciccolo A, Arrigo C, Aloi G, Micali C, La Torre F: Spontaneous rupture of spleen during periferal blood stem cell mobilization in a patient with breast cancer. Haematologica (2000) 85(5):559-560.
33. Adkins DR, Goodnough LT, Shenoy S, Brown R, Moellering J, Khoury H, Vij R, DiPersio J: Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. Blood (2000) 95(11):3605-3612.
34. Strong DM, Katz L: Blood-bank testing for infectious diseases: How safe is blood transfusion? Trends Mol Med (2002) 8(7):355-358.
35. Dana BW, Durie BG, White RF, Huestis DW: Concomitant administration of granulocyte transfusions and amphotericin B in neutropenic patients: Absence of significant pulmonary toxicity. Blood (1981) 57(1):90-94.
36. Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB: Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med (1981) 304(20):1185-1189.
37. Dutcher JP, Kendall J, Norris D, Schiffer C, Aisner J, Wiernik PH: Granulocyte transfusion therapy and amphotericin B: Adverse reactions? Am J Hematol (1989) 31(2):102-108.
38. Boxer LA, Ingraham LM, Allen J, Oseas RS, Baehner RL: Amphotericin-B promotes leukocyte aggregation of nylon-wool-fiber-treated polymorphonuclear leukocytes. Blood (1981) 58(3):518-523.
39. Leavey PJ, Thurman G, Ambruso DR: Functional characteristics of neutrophils collected and stored after administration of G-CSF. Transfusion (2000) 40(4):414-419.
40. Lightfoot T, Leitman SF, Stroncek DF: Storage of G-CSF-mobilized granulocyte concentrates. Transfusion (2000) 40(9):1104-1110.
41. Price TH: The current prospects for neutrophil transfusions for the treatment of granulocytopenic infected patients. Transfus Med Rev (2000) 14(1):2-11.